Developing a vaccine against Zika

BMJ (Online)

Volumn 355, Issue , 2016, Pages

  Hombach, Joachim ^a   Friede, Martin ^a   Moorphy, Vasee ^a   Costello, Anthony ^a   Kieny, Marie Paule ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ZIKA VIRUS VACCINE; VIRUS VACCINE;

DRUG CONTROL; EVIDENCE BASED PRACTICE; FLAVIVIRUS; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; INFANT DISEASE; LICENSING; MICROCEPHALY; NONHUMAN; NOTE; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; PUBLIC HEALTH; STUDY DESIGN; TARGET PRODUCT PROFILE; VACCINE PRODUCTION; WOMEN'S HEALTH; WORLD HEALTH ORGANIZATION; ZIKA FEVER; AEDES; ANIMAL; IMMUNOLOGY; INSECT VECTOR; VIROLOGY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

AEDES; ANIMALS; HUMANS; INSECT VECTORS; VIRAL VACCINES; WORLD HEALTH ORGANIZATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84995488141     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i5923     Document Type: Note

References (5)

1. WHO. Current Zika production pipeline, 3 March 2016. http://www.who.int/csr/researchand-development/zika-rd-pipeline.pdf?ua=1
2. WHO. Vaccine pipeline tracker. 2016, http://www.who.int/immunization/research/vaccine-pipeline-tracker-spreadsheet/en/
3. WHO. A research and development blueprint for action to prevent epidemics. 2016. http://www.who.int/csr/research-and-development/en/
4. WHO, Unicef. Zika virus vaccine target product profile for emergency use. 2016. http://www.who.int/immunization/research/meetings-workshops/WHO-Zika-vaccine-TPP.pdf?ua=1
5. WHO. Designing a vaccine efficacy trial during public health emergencies: progress in developing adequate study designs. 2016. http://www.who.int/csr/research-anddevelopment/consultations/chamonix-meeting/en/